Miso Clinic · Treatment comparison

XERF versus Thermage: the difference

XERF is often introduced as “the Korean Thermage”. Let us see how far that holds. And first, plainly: Miso Clinic does not have Thermage.

Treatment comparisonAbout a 5-minute readSeptember 2026Miso Clinic, Daegu · Dr. Lee Chi-Hak

The short answer

XERF and Thermage are both 6.78 MHz monopolar RF, the same class of principle. What differs: XERF adds a 2 MHz frequency to heat fat layer and fibrous septa differently, uses four handpieces of different sizes, and received US FDA 510(k) clearance in August 2025. Thermage’s evidence base is far deeper. XERF has three human studies and 75 people, all single-arm. No head-to-head exists. Miso Clinic does not have Thermage.

In one table

XERF and Thermage
XERFThermage (FLX etc.)
MakerLutronic (Korea)Solta Medical (USA)
ModeMonopolarMonopolar
Frequency6.78 + 2 MHz6.78 MHz
Handpieces / tipsFour (i05 400, i10 300, E40 600, E60 600 shots)EYE 450 REP, TOTAL 600 REP, etc.
Surface protectionCryogen sprayCryogen spray
EndpointHeat feedbackHeat feedback 2.0–2.5 (manual)
US FDA510(k) K251327 (2025-08)Cleared (long-standing)
Human dataThree studies, 75 people, single-armMany, mostly uncontrolled
Head-to-headNoneNone
AnaestheticUsually not neededBy condition
At Miso ClinicYesNo

Why add 2 MHz

Frequency relates to where heat concentrates. Modelling and porcine histology showed 2 MHz heating the fat layer broadly and deep, 6.78 MHz heating locally along the fibrous septa. XERF chooses between them by zone. Whether that changes results in humans has not been confirmed.

How far “Korean Thermage” holds

Same 6.78 MHz monopolar class and the same heat-feedback endpoint. Different: one extra frequency, a different handpiece set, and a very different depth of evidence. So “a different device on the same principle” is the accurate phrase. Which gives the better result has never been compared.

If you want Thermage

A clinic that has it is the right place, and we do not hesitate to say so. Miso Clinic covers layers and zones with XERF, Density and Oligio Kiss, and XERF is the one we put first for no-downtime, zone-by-zone work.

Which treatment fits which concern

Which treatment fits which concern
ConcernTreatments to considerWhy
Want the deepest evidence baseThermage (not at Miso Clinic)We say so plainly
No downtime, by zone, US FDA clearedXERFFour handpieces
Thicker skin, deeper saggingDensitySequential polarity
Sagging into the deeper layerOligio KissFocused ultrasound added
Thin, papery skinBooster class firstNot the RF layer

Which treatment is “best” is decided by the state of your skin right now, not by the product. In consultation we look first at what has been lost and what is still there, before we talk about any product name.

Frequently asked questions

Is XERF less painful than Thermage?

No comparison data. XERF usually runs without anaesthetic, but pain depends on zone and intensity.

Is 600 XERF shots the same as 600 Thermage shots?

Not if handpiece areas differ. Compare XERF E40 with the Thermage TOTAL tip area.

Is XERF FDA approved?

It has 510(k) clearance from August 2025. 510(k) means substantially equivalent to an existing device, not that a separate efficacy trial was passed.

Read next

If you want to go deeper

Product page

Who wrote this

Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Studies are cited with their size and limitations, and where we could not find data we say so. Individual decisions need an in-person examination; this page does not replace one.

Miso Clinic
Medical directorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station
Phone+82-53-428-2700
KakaoTalkMiso Clinic channel
HoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 / Closed Sundays and public holidays
Treatment guidesAll guides
ComparisonsAll comparisons
ColumnsAll clinical columns
Reference libraryAll booster and device references

References

  1. Lutronic XERF product material — monopolar RF, 6.78 MHz + 2 MHz, four handpieces (XERF i05, i10; EFFECTOR E40, E60). MFDS-approved device. US FDA 510(k) K251327 (2025-08-11).
  2. XERF human studies, three — 20 people single-arm 12 weeks (Medical Lasers 2025), 39 people multicentre 90 days (Cureus 2026, manufacturer-supported), 16 people retrospective 3 months (Lasers Med Sci 2026). No control group in any.
  3. Thermage CPT Technical User’s Manual (Solta, 2021, NP009240-06) — endpoint heat feedback 2.0–2.5 on 0–4. No recommended total REP count for the face.
  4. Dover JS & Zelickson B, Dermatol Surg 2007;33(8):900–907 — the shift to low-energy multiple passes; survey of 14 physicians.
  5. Chapas A et al., JDD 2020;19(1):20–26 — international Delphi consensus, 19 recommendations. “Device specific guidelines are lacking.”

Everything on this page is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Comparisons · Clinical columns · Reference library · Miso Clinic home

한국어 · English